84 results
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
4 Mar 24
Entry into a Material Definitive Agreement
5:22pm
by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
31 Jan 24
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
9:00am
of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested in good
424B5
3u6up9kfi8l3u71d0
31 Jan 24
Prospectus supplement for primary offering
8:59am
8-K
EX-1.1
hhg7y
12 Oct 23
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
5:04pm
8-K
EX-99.2
htvrp0 m64rqh
11 Oct 23
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio
5:14pm
8-K
EX-1.1
3qakv
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
424B5
t611 dzevw7
15 Dec 22
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.2
idtt09mcjcawwgro49
15 Dec 22
Astria Therapeutics Announces Positive Preliminary Results from the Phase 1a Clinical Trial of STAR-0215 in Healthy Subjects
6:00am
424B5
la63re6r
10 Nov 22
Prospectus supplement for primary offering
4:05pm
424B5
t4ldr7tbi21klhu7j
16 Sep 22
Prospectus supplement for primary offering
4:08pm